Deals
Ropes & Gray has advised Reed & Mackay, an international travel management company, on its acquisition of Hillgate Travel, a leading UK-based travel management company.
The financial terms of the deal have not been disclosed.
The deal takes Reed & Mackay’s global turnover past the GBP600 million mark. With both businesses in growth phase, the acquisition will see the collective business accelerate the evolution of their suite of industry-leading technology, across the key international markets of their client base.
The Ropes & Gray team was led by private equity partner Phil Sanderson. Other members of the team included finance
L Squared Capital Partners has made a growth investment in Kanopy, its eighth platform investment over the past four years.
Headquartered in San Francisco, Kanopy is a streaming video platform that offers millions of professors, students, and public library patrons free and convenient access to a unique collection of 30,000 highly curated films and documentaries. Kanopy has emerged as the leading destination for thoughtful educational entertainment with content ranging from award winning independent films and documentaries to cinematic classics to engaging lifelong learning course modules.
Kanopy’s CEO & Founder Olivia Humphrey, says: “We are thrilled to partner with the
Consumer-focused private equity firm L Catterton is to make a strategic investment in Goiko Grill, one of Spain’s most successful casual dining concepts.
Founded in Madrid in 2013, Goiko Grill is the fastest growing full-service restaurant chain in the Spanish gourmet burger casual dining space. The Company currently operates 44 locations in Spain, delivering daily on its customer promise of “the best burgers and the best service, efficiency and good vibes” to an increasing numbers of patrons. Goiko Grill benefits from an unmatched brand awareness and visibility in the Spanish restaurant market thanks to its high exposure on social media,
Sovereign Capital Partners has realised its investment in Linnaeus Group, one of the UK’s leading veterinary services providers, in a sale to Mars Petcare’s Veterinary Health Group, a part of Mars, Incorporated.
The exit, Sovereign’s largest ever sale, will generate Sovereign’s strongest ever gross return, although no financial terms are able to be disclosed. This is the seventh exit from Sovereign’s third fund – SCLP III.
Sovereign backed the original veterinary platform, Willows Veterinary Centre and Referral Service, one of the leading specialist veterinary centres for small animals in the UK, in September 2014. At the time of the
Sentinel Capital Partners, a private equity firm that invests in promising companies at the lower end of the midmarket, has acquired GSM Outdoors, a provider branded accessories for the hunting, sport shooting, and outdoor enthusiast markets.
Terms of the deal have not been disclosed.
Headquartered in Grand Prairie, Texas, GSM has a broad portfolio of innovative hunting and sport shooting products sold under highly recognised brand names. GSM’s industry leading brands include Stealth Cam (technologically advanced game scouting cameras); Walker’s (hearing protection and enhancement devices); Cyclops (specialty outdoor lighting); Western Rivers (game calls); American Hunter (game feeders); HME (hunting
Northrop Grumman Corporation has closed its acquisition of Orbital ATK, a specialist in aerospace and defence technologies. Orbital ATK is now Northrop Grumman Innovation Systems, a new, fourth business sector.
Northrop Grumman’s board of directors has elected Blake Larson as corporate vice president and president of Northrop Grumman Innovation Systems, reporting to Kathy Warden, Northrop Grumman’s president and chief operating officer. Larson previously served as the chief operating officer of Orbital ATK.
“We welcome Orbital ATK’s talented employees,” says Wes Bush, chairman and chief executive officer, Northrop Grumman. “We are delighted to have them join the Northrop Grumman team,
Private equity firm Silverfleet Capital has agreed to sell Ipes, a provider of outsourced service,s including fund administration, to the European private equity sector, to Apex Group Ltd.
The transaction, which is expected to generate a 3.8-times money multiple and 30 per cent IRR for Silverfleet once completion, adds USD165 billion in assets under administration to Apex’s portfolio.
Ipes was founded in 1998 and pioneered a specialist approach to fund administration within the European Private Equity market. Ipes’ team of 265 people located in five European offices works with 195 clients and provides administration and depositary oversight to 390
Kerry Logistics Network Limited has acquired a majority stake in Milan-based logistics company Saga Italia, as part of its ongoing global expansion strategy.
The acquisition will also add three new countries to Kerry Logistics’ network – the Republic of the Congo, Uganda, and Egypt, as well as new offices in Kazakhstan, Turkmenistan, United Arab Emirates, Russia, and the US.
Founded in 1985, Saga Italia provides end-to-end solutions tailored to its customers’ project requirements. More than 150 logistics professionals manage projects for multinational corporations across the globe, particularly for customers in the oil and gas industry. Saga Italia’s comprehensive range
Great Rock Capital, an asset-focused commercial finance company specialising in middle market lending, has completed a GBP25 million secured term loan for Zacky & Sons Poultry, a vertically integrated grower, processor, and distributor of premium poultry products.
In addition, Great Rock Capital partnered with GemCap Solutions, an innovative lending firm that provides senior-secured, commercial asset-based loans, which provided a GBP16 million revolving loan.
The capital will enable Zacky & Sons to refinance existing senior indebtedness and fund capital expenditures to expand its production facilities to support the company’s growth.
“We are excited about our partnership with Great Rock
Gide has advised ENYO Pharma on its EUR40 million Series B round of financing from US and European investors.
ENYO Pharma is a clinical stage biotech company developing innovative drug candidates by mimicking virus strategies to modulate host cellular functions. This very significant funding will enable the company to finance the two first Phase II clinical trials of its EYP001 asset in both chronic HBV and NASH. A second asset is also expected to enter the clinic by 2019.
This round was led by OrbiMed, followed by Andera Partners and Bpifrance Large Venture as new shareholders. Existing shareholders Sofinnova
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
